$4.84 $0.02 (0.4%)

04:00 PM EST on 12/06/19

Endo International (NASDAQ:ENDP)

CAPS Rating: 4 out of 5

A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.

Current Price $4.84 Mkt Cap $1.1B
Open $4.95 P/E Ratio 0.00
Prev. Close $4.82 Div. (Yield) $0.00 (0.0%)
Daily Range $4.81 - $5.08 Volume 5,395,497
52-Wk Range $1.97 - $12.49 Avg. Daily Vol. 9,013,865

Caps

How do you think NASDAQ:ENDP will perform against the market?

Add Stock to CAPS Watchlist

All Players

406 Outperform
26 Underperform
 

All-Star Players

66 Outperform
5 Underperform
 

Wall Street

12 Outperform
3 Underperform
 

Top NASDAQ:ENDP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Raphael1990 (27.52)
Submitted February 15, 2014

A little less than a year ago this was just another pharmaceutical company facing declining revenues due to patent expiration (Lipoderm). And then their new CEO Rajiv de Silva came along. This is a big deal because he is a former member of Valeant… More

shahart (50.28)
Submitted September 01, 2011

The last patent for Lidoderm expires in 2014. Lidoderm is responsible for aroung 35% of current revenues, but more importantly, around 50% of gross profit.Bracing itself for the Lidoderm's patent expiration, the management started a serious of… More

Recent Community Commentary

Read the most recent pitches from players about ENDP.

Recs

0
Member Avatar aeroberts831 (< 20) Submitted: 3/5/2018 9:21:14 PM : Underperform Start Price: $7.24 NASDAQ:ENDP Score: +48.35

Endo is being sued by over 12 states/cities for fraudulent marketing tactics; my research leads me to believe the lawsuits are justified & Endo is going to face a tobacco-level payout in the near future.

Recs

0
Member Avatar cozmick (< 20) Submitted: 3/1/2017 12:44:58 PM : Outperform Start Price: $12.72 NASDAQ:ENDP Score: -93.24

Market overlooking pipeline and over-reacting to leverage and political pressure on drug prices.

Recs

0
Member Avatar jer (21.42) Submitted: 2/9/2017 5:21:51 PM : Outperform Start Price: $12.12 NASDAQ:ENDP Score: -96.36

Aging populations NEED generic meds!!

Leaderboard

Find the members with the highest scoring picks in ENDP.

Score Leader

mikep757

mikep757 (< 20) Score: +361.55

The Score Leader is the player with the highest score across all their picks in ENDP.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
mikep757 < 20 2/11/2009 Underperform 3Y $22.06 -78.06% +283.49% +361.55 0 Comment
everything4less 79.35 11/19/2008 Underperform 3W $20.15 -75.98% +275.99% +351.97 0 Comment
MNNice < 20 2/9/2009 Underperform 1Y $23.38 -79.30% +268.45% +347.75 1 Comment
pinkdiamond 38.76 9/16/2008 Underperform NS $21.15 -77.12% +177.04% +254.15 0 Comment
str8nuts < 20 1/20/2010 Underperform 5Y $20.18 -76.02% +175.51% +251.52 0 Comment
EagleTraderOne < 20 9/11/2008 Underperform 3W $20.76 -76.69% +166.04% +242.73 1 Comment
shahart 50.28 9/1/2011 Underperform 5Y $31.83 -84.79% +157.46% +242.26 1 Comment
Okcfirefighter < 20 12/17/2010 Underperform 5Y $35.57 -86.39% +153.12% +239.51 0 Comment
sjcollector 49.22 7/25/2008 9/16/2008 Underperform 3Y $25.20 -80.79% +158.18% +238.98 0 Comment
skiprof < 20 8/4/2008 Underperform 3M $22.99 -78.95% +159.04% +237.98 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ENDP.